






Awake craniotomy has been adopted for the surgical treat-
ment of intractable epilepsy more than 100 years ago, and is 
now considered as a gold standard of care for resection of 
tumors, such as primarily gliomas, located within or close to 
the eloquent areas (i.e., sensorimotor or language areas) of 
the brain [1,2]. The modern awake craniotomy techniques 
have evolved in combination with intraoperative neuro-
physiologic monitoring to identify the eloquent areas of the 
brain. An optimal tumor resection is the maximal removal of 
mass without any significant neurological deficit, such as 
motor or language function damage, for most brain tumors. 
The cortical mapping during awake craniotomy enables the 
identification of cortical and subcortical networks for indi-
vidual patients’ neurological functions. Compared with cra-
niotomy under general anesthesia, awake craniotomy can 
provide wider extent of tumor removal without postopera-
tive neurologic deficits and improved survival rates of pa-
tients. Therefore, it is now considered as the treatment of 
choice for surgery of brain tumor in the eloquent areas [3,4]. 
Smooth intraoperative emergence and adequate communi-
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cation between the surgeons and patients are important an-
esthetic considerations in this surgery, and are the key fac-
tors for successful awake craniotomy. 
ANESTHETIC ADVANTAGES OF AWAKE 
CRANIOTOMY 
Awake craniotomy has several anesthetic benefits and 
surgical advantages. Patients undergoing awake cranioto-
my can avoid general anesthesia-related procedures, such 
as endotracheal intubation and mechanical ventilation. 
General anesthesia-related hemodynamic and physiologic 
disturbances are reduced, and postoperative pain, nausea, 
and vomiting are reduced in awake craniotomy compared 
with the craniotomy under general anesthesia [5,6]. The 
surgical and anesthetic advantages of awake craniotomy 
are listed in Table 1.  
Generally, inhalational anesthetic agents are rarely used 
in awake craniotomy, unless endotracheal intubation or 
insertion of laryngeal mask airway are performed, and only 
small dose of intravenous agents, such as propofol, is used 
[7]. Analgesia during awake craniotomy is mainly achieved 
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by the scalp nerve block with local anesthetic agents. 
Therefore, hypotension associated with general anesthesia 
is uncommon during awake craniotomy and subsequently, 
vasopressors are used less than that during general anes-
thesia [8]. Hence, patient’s hemodynamic and physiologic 
status can be more stable in awake craniotomy than that in 
general anesthesia. 
Possible adverse effect of general anesthetic agents, in-
cluding inhalation anesthetic agents and opioids on cancer 
prognosis, such as increased recurrence or metastasis after 
the surgery, has been reported recently [9,10]. In contrast, 
local anesthetics can directly inhibit some cancer cells 
even though this effect seems agent specific [11]. However, 
the impact of avoiding general anesthesia during awake 
craniotomy on brain tumor prognosis has not been evalu-
ated in prospective, randomized, and controlled trials. 
Awake craniotomy is also associated with shorter hospi-
tal stay compared with the craniotomy under general anes-
thesia [12], potentially reducing the risks of hospital-ac-
quired infection and deep vein thrombosis [13]. 
PREOPERATIVE PREPARATION 
Awake craniotomy requires a highly cooperative patient 
and an expert surgical team. Appropriate patient selection 
and preparation are essential for the success of awake crani-
otomy. Preoperative airway evaluation should be performed 
in all patients. Although a patient with a difficult airway or 
obstructive sleep apnea is a poor candidate for awake crani-
otomy, but only the patient’s refusal is considered as an ab-
solute contraindication for awake craniotomy [6]. 
Control of preoperative anxiety before awake craniotomy 
is important and can be relieved by proper preoperative 
counseling about the anesthetic and surgical procedures. 
Therefore, preoperative consultation by anesthesiologist is 
an important process [14,15]. The anesthesiologist should 
outline the overall awake craniotomy procedures including 
the positioning, scalp nerve block, the possible discomfort, 
and the motor and language test. A good anesthesiolo-
gist-patient relationship is essential and the anesthesiolo-
gist should attempt to alleviate anxiety and discomfort of 
the patient as much as possible to ensure the success of 
awake craniotomy [15]. 
ANESTHETIC APPROACHES FOR AWAKE 
CRANIOTOMY: OVERVIEW 
Various anesthetic techniques may be useful for awake 
craniotomy. Among them, there are two commonly used 
anesthetic methods for awake craniotomy: monitored an-
esthesia care (MAC) and asleep-awake-asleep (AAA) tech-
nique [4–6]. The anesthesiologists should provide sufficient 
sedation and analgesia during the initial craniotomy, a 
rapid and smooth emergence of patients is required for in-
traoperative neurophysiologic test including motor and 
language test, and brain mapping. After the tumor resec-
tion, sedation is often sufficient until completion of the 
surgery. The overall stages of awake craniotomy and anes-
thetic techniques are presented in Table 2. The sedation 
profile during the first stage of awake craniotomy, from 
scalp incision to dura opening, plays a pivotal role in the 
quality of intraoperative consciousness. The anesthesiolo-
gist should restore the consciousness of patient back to the 
preoperative state for neurophysiologic tests and brain 
mapping to be performed successfully. 
In the MAC technique, adequate depth of sedation and 
Table 1. Advantages of Awake Craniotomy
Surgical aspects
 Better preservation of motor & speech function
 Shorter hospitalization
 Reduced postoperative neurologic deficits
 Improved survival
Anesthetic aspects
 Less physiological disturbance
 Avoidance of mechanical ventilation
 Avoidance the adverse impact on immunity associated with general 
anesthesia
Table 2. The Stages of Awake Craniotomy and Anesthetic Options
Stages Pre-awake stage Awake stage Post-awake stage




 AAA GA (ETT or LMA) Awake GA or MAC
 MAC MAC Awake MAC
AAA: asleep-awake-asleep, GA: general anesthesia, ETT: endotracheal tube, LMA: laryngeal mask airway, MAC: monitored anesthesia care.
270 www.anesth-pain-med.org





Cspontaneous ventilation are maintained using low doses of 
sedative agents to avoid a sudden recovery from asleep 
state, which could be a risk factor for delirium on emer-
gence and decrease neurophysiologic tests or brain map-
ping reliability. In contrast, the AAA technique uses higher 
doses of sedative agents. The target depth of AAA tech-
nique ranges from deep sedation to general anesthesia us-
ing mechanical ventilation, commonly by a laryngeal mask 
airway. The benefits of this technique as compared to the 
MAC technique are better comfort and pain control for the 
patient, and securing the patient’s airway during the first 
stage of awake craniotomy. This approach is also advanta-
geous for controlling brain swelling via hyperventilation 
and prevention of accidental patient movements. 
Although there are significant differences in these two 
techniques, both the MAC and AAA techniques can be per-
formed successfully in awake craniotomy and are found to 
be safe [16]. In a recent retrospective analysis comparing 
the MAC and AAA technique for awake craniotomy in a 
single center, both the techniques were equally effective 
and safe, and produced comparable perioperative out-
comes, with a shorter duration of surgery in the MAC tech-
nique [17]. In another retrospective analysis comparing the 
effectiveness of the MAC and AAA techniques in 64 pa-
tients undergoing supratentorial brain tumor resection, the 
incidence of seizures and agitation were higher in the MAC 
group than that in the AAA group. However, blood pressure 
was higher and more antihypertensive treatment was re-
quired in the AAA group than that in the MAC group during 
the neurophysiologic examination [18]. Therefore, with a 
good cooperation among anesthesiologists, surgeons, and 
neurophysiologists, the MAC technique can be performed 
successfully with similar safety and comfort for the patients 
compared to the AAA technique [19]. 
ANESTHETIC APPROACHES FOR AWAKE 
CRANIOTOMY: SEDATIVE COMPONENTS 
A combination of propofol and remifentanil has been 
considered as the standard protocol for sedation during 
the first stage of awake craniotomy because of the ease of 
use and reliability [6,20]. The propofol and remifentan-
il-based AAA technique allows a smooth emergence and 
rapid recovery of consciousness for intraoperative neuro-
physiologic testing [21]. The main disadvantage of this ap-
proach is the potential risk of delirium on emergence be-
fore intraoperative neurophysiologic testing and brain 
mapping [6]. The propofol and remifentanil-based MAC 
technique is associated with dose-dependent respiratory 
depression, which can produce hypercapnia and subse-
quent brain edema. Therefore, achieving the optimal seda-
tion level for an individual is crucial. Meanwhile, light se-
dation has the risk of causing accidental patient movement 
and anxiety is likely. Generally, state of drowsiness but 
readily responsive is considered as the optimal sedation in 
awake craniotomy [6], and experienced anesthesiologists 
are required to accomplish this balance in the complex set-
ting of awake craniotomy. The electroencephalography-de-
rived monitors, such as the electroencephalogram-derived 
bispectral index, and target-controlled infusion of propofol 
and remifentanil can be useful for this setting. The Schnei-
der model is recommended for the target-controlled infu-
sion of propofol in awake craniotomy for maintaining pa-
tients’ spontaneous ventilation [22]. 
Dexmedetomidine an alternative to propofol for the 
MAC technique during awake craniotomy can also be 
used. It is a selective alpha-2 agonist with sedative, analge-
sic, anxiolytic, and sympatholytic properties. The advanta-
geous effects of dexmedetomidine, such as minimal effect 
on neurophysiologic monitoring, stable hemodynamics, 
and minimal respiratory depression, makes it suitable for 
sedation during awake craniotomy [23]. In a recent study 
comparing propofol-remifentanil and dexmedetomidine 
during awake craniotomy in patients undergoing supraten-
torial tumor resection, dexmedetomidine provided com-
parable surgical environment in terms of quality of intra-
operative brain mapping and efficacy of sedation, with less 
respiratory adverse events compared with the propo-
fol-remifentanil group [24]. Similarly, a retrospective co-
hort study including 55 patients demonstrated that dexme-
detomidine and the scalp nerve block were used success-
fully in awake craniotomy without any urgent airway inter-
vention or unplanned conversion to general anesthesia 
[25]. Although high dose of dexmedetomidine may cause 
bradycardia, significant inter-individual variability of the 
sedative state, and a prolonged recovery from sedation af-
ter the cessation of infusion, such a high dose is not re-
quired during awake craniotomy. Moreover, it is especially 
useful for high-risk patients or when prolonged duration of 
surgery is anticipated [26]. 
Inhalational anesthetics, such as sevoflurane, are also 
used for the AAA technique in awake craniotomy. Howev-
er, these agents have the potential to increase intracranial 
pressure and induce nausea and vomiting during awake 
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stage. A new inhalational anesthetic, xenon has potential 
advantages for awake craniotomy because of its neuropro-
tective properties and rapid emergence [27]. 
ANESTHETIC APPROACHES FOR 
AWAKE CRANIOTOMY: ANALGESIC 
COMPONENTS 
The mainstay of analgesia for awake craniotomy is a re-
gional block, and there are two main approaches: the re-
gional scalp block along with incision line infiltration, and 
the scalp nerve block for six nerves, which provide sensory 
innervation to the scalp [28]. Adequate regional blocks 
make the patient tolerable for the surgery and enables bet-
ter patient satisfaction after surgery in terms of pain com-
pared with general anesthesia. However, even when re-
gional blocks are successfully performed, patients often ex-
perience and complain of pain during surgery. Usually, 
these sensations are associated with manipulations of the 
skull-base structures or traction of pain-sensitive intracra-
nial structures [29]. Additional opioids may lead to poor 
cooperation of the patient and reduced reliability of brain 
mapping [6]. Adequate preoperative patient information 
and preparation, expert anesthesiologists, and surgical 
technique to avoid traction of pain-sensitive intracranial 
structures are the cornerstone to improve intraoperative 
pain management and ensure postoperative patient’s satis-
faction. 
COMPLICATIONS OF AWAKE 
CRANIOTOMY 
Seizures, hypertension, respiratory depression, nausea 
and vomiting, and mild brain swelling may occur during 
awake craniotomy [17]. Macroglossia [30] and accidental 
intracerebral injection of local anesthetics during scalp 
nerve block [31] have also been reported. Although com-
plications during awake craniotomy are minor and easily 
manageable, urgent intervention should be performed for 
seizures and airway obstruction. A recent meta-analysis 
demonstrated that failure of awake craniotomy, defined as 
failure to achieve complete awake brain mapping occurs in 
<  2% cases, and the incidence of adverse events, such as 
seizures, conversion to general anesthesia, and new post-
operative neurologic dysfunction, were similar between 
the AAA and MAC techniques [2]. 
The frequency of seizures during awake craniotomy was 
reported to vary between 2.9 and 54% in a multicenter ret-
rospective study of 823 cases of intraoperative brain map-
ping [32]. The main risk factors for intraoperative seizure 
are history of preoperative seizure and frontal lobe tumors, 
and preoperative antiepileptic medication does not reduce 
the incidence of seizures [32,33]. Intraoperative seizures 
mainly occur due to electrical cortical stimulation during 
brain mapping, and the seizures can be easily controlled by 
cortical surface irrigation with cold saline by the surgeon. 
If this is ineffective, low doses of intravenous propofol can 
be administered [6]. The efficacy of antiepileptic drugs for 
intraoperative seizure prevention remains debatable. In a 
systematic review, antiepileptic drug prophylaxis did not 
show benefits of seizures prevention in brain tumor resec-
tion [34]. Another systematic review and meta-analysis re-
ported that the efficacy of levetiracetam is superior to that 
of phenytoin and valproate in terms of seizure prevention 
[35]. However, evidence encouraging the routine use of an-
tiepileptic drugs in awake craniotomy remains limited. 
Airway obstruction is another serious complication en-
countered in awake craniotomy, but can be solved by sim-
ple intervention, such as jaw thrust and supplemental oxy-
gen. In anticipation of airway emergencies, a full range of 
airway equipment including laryngeal mask airway, video 
laryngoscope, and endotracheal tube should be immedi-
ately available [6]. Moreover, it should be considered that 
laryngeal mask airway insertion, or endotracheal intuba-
tion are difficult in patients with semi-lateral position 
whose head is turned with a head frame. 
FUTURE CONSIDERATIONS FOR AWAKE 
CRANIOTOMY 
Awake craniotomy may be considered not only in brain 
tumor and epilepsy surgery, but also in other neurosurgical 
procedures, such as cerebral aneurysm clipping and exci-
sion of arteriovenous malformations [36,37]. 
Awake craniotomy has been performed to minimize the 
risk of motor and language function damage. However, an 
increasing interest is seen in the adoption of awake crani-
otomy for brain tumors located in the non-dominant 
hemisphere area, which is responsible for visuospatial and 
social cognition. Preservation of such functions is import-
ant especially for patients with low-grade glioma to return 
to their daily lives quickly after the surgery, and expect lon-
ger survival [38]. However, precise brain mapping of 
non-dominant hemisphere functions is particularly diffi-
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Ccult due to complexity of its functional anatomy. Therefore, 
it is necessary to develop adequate methods to assess large 
spectrum of cognition during awake brain surgery [39]. 
CONCLUSION 
Anesthesia for awake craniotomy is one of the most chal-
lenging fields for anesthesiologists. Awake craniotomy is 
advantageous because it can perform extended range of 
tumor resection with less risk of neurological deficits in-
cluding motor and speech function damage, compared 
with craniotomy under general anesthesia. Both the MAC 
and AAA techniques are feasible and safe anesthetic tech-
niques for awake craniotomy, and adequate regional block 
is required for effective intraoperative pain control and 
better patient satisfaction. Appropriate patient selection, 
perioperative psychological support, and proper anesthetic 
management for individual patients in each stage of sur-
gery are crucial for procedural safety, success, and patient 
satisfaction. 
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